Allurion Technologies (ALURD) Other Non-Current Assets (2022 - 2026)

Allurion Technologies (ALURD) Other Non-Current Assets (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Abbott Laboratories 186.78 Bn 179.48 Bn 6.27 Bn -
2 Stryker 131.95 Bn 129.07 Bn 3.81 Bn 3.17 Bn
3 Medtronic 111.27 Bn 102.05 Bn 6.41 Bn 4.15 Bn
4 Boston Scientific 68.58 Bn 67.13 Bn 3.61 Bn 2.05 Bn
5 Edwards Lifesciences 48.31 Bn 44.63 Bn 1.29 Bn 738.90 Mn
6 GE HealthCare Technologies 29.23 Bn 26.94 Bn 1.98 Bn 2.25 Bn
7 Dexcom 28.90 Bn 27.78 Bn 750.30 Mn 285.90 Mn
8 Smith & Nephew 28.19 Bn 27.62 Bn - 164.00 Mn
9 Koninklijke Philips 24.33 Bn 21.29 Bn 2.01 Bn 805.67 Mn
10 Allurion Technologies 60.75 Mn 55.69 Mn 1.23 Mn 633,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 633,000.00
Dec 31, 2025 663,000.00
Sep 30, 2025 953,000.00
Jun 30, 2025 997,000.00
Mar 31, 2025 1.08 Mn
Dec 31, 2024 1.11 Mn
Sep 30, 2024 507,000.00
Jun 30, 2024 510,000.00
Mar 31, 2024 510,000.00
Dec 31, 2023 505,000.00
Sep 30, 2023 354,000.00
Jun 30, 2023 9.17 Mn
Dec 31, 2022 2.71 Mn